Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 11Genitourinary 6Thoracic 4Lymphoid 4Other hematologic neoplasm 3Plasma cell 2Head & Neck 2Sarcoma 1Other neoplasm 1Gynecologic 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Ovarian Neoplasms 1773Uterine Cervical Neoplasms 1499Endometrial Neoplasms 833Breast Neoplasms 434Carcinoma, Ovarian Epithelial 405Fallopian Tube Neoplasms 399Uterine Cervical Dysplasia 276Neoplasms 252Colorectal Neoplasms 179Uterine Neoplasms 173Peritoneal Neoplasms 170Vulvar Neoplasms 155Lung Neoplasms 150Pancreatic Neoplasms 141Prostatic Neoplasms 135Recurrence 128Stomach Neoplasms 126Colonic Neoplasms 116Papillomavirus Infections 115Melanoma 101Sarcoma 97Urinary Bladder Neoplasms 95Vaginal Neoplasms 93Carcinoma, Non-Small-Cell Lung 92Head and Neck Neoplasms 91Neoplasm Metastasis 83Esophageal Neoplasms 82Testicular Neoplasms 80Rectal Neoplasms 71Kidney Neoplasms 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Patient Participation × Gynecologic × Clear all
NCT05256576 2025-01-15

KORE

Charite University, Berlin, Germany

Phase NA Completed
465 enrolled
Gynecologic

Frailty, Fallopian Tube Neoplasms, Ovarian Neoplasms, Patient Participation, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡